Supplementary Methods and Supplementary Results from MALAT1 is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance Through EZH2

Peilong Li,Xin Zhang,Haiyan Wang,Lili Wang,Tong Liu,Du Li,Yue Yang,Chuanxin Wang
DOI: https://doi.org/10.1158/1535-7163.22509042.v1
2023-01-01
Abstract:Supplementary methods and Supplementary results
What problem does this paper attempt to address?